The Multiple Myeloma Channel on VJHemOnc is an independent medical education platform, supported with funding from BMS (Gold) and Legend Biotech (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
IMS 2023 | A prognostic survival model incorporating PROs for elderly patients with multiple myeloma
In this video, Hira Mian, MD, McMaster University, Hamilton, Canada, discusses the development of a prognostic survival model incorporating patient reported outcomes (PROs) which has been designed to assist in making treatment decisions for elderly patients with multiple myeloma. This interview took place at the 20th International Myeloma Society (IMS) Annual Meeting, held in Athens, Greece.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
